
    
      The drug being tested in this survey is called vonoprazan. Vonoprazan is being tested to
      treat people who have gastric or duodenal ulcers.

      This survey will look at the safety and effectiveness of long-term administration of
      vonoprazan tablets for up to 12 months in the routine clinical setting in patients receiving
      low-dose aspirin.

      The survey will enroll approximately 1,000 participants.

      - Vonoprazan 10 mg

      This multi-center observational survey will be conducted in Japan.
    
  